TransMedics Group, Inc.
TMDX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
TransMedics Group, Inc., společnost zabývající se lékařskou technikou v komerčním měřítku, se zabývá transformací transplantační terapie pro pacienty s selháním orgánů v konečném stadiu ve Spojených státech a mezinárodně. Společnost nabízí Organ Care System (OCS), přenosný perfuzní, optimalizační a monitorovací systém, který využívá vlastní a přizpůsobenou technologii k replikaci téměř fyziologických stavů dárcovských orgánů mimo lidské tělo. Jeho systém péče o orgány zahrnuje OCS LUNG pro zachování standardních kritérií dárcovské plíce pro transplantaci dvojité plíce; OCS Heart, technologii pro mimotělní perfuzi a uchování dárcovských srdcí; a OCS Játra pro uchování dárcovských jater. Společnost byla založena v roce 1998 a sídlí v Andoveru ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
728
Založení
2019-05-02
Podobné společnosti
$ 27.65
- $ 0.01
$ 86.69
+ $ 2.83
$ 54.12
+ $ 0.08
$ 15.02
- $ 2.70
$ 23.05
- $ 0.30
$ 59.70
+ $ 1.04
$ 39.09
+ $ 2.33
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 605.5 | 605.5 | 441.5 | 241.6 | 93.5 | 30.3 | 25.6 | 23.6 | 13.0 | 7.7 | 6.2 | |
| Cost of Revenues | 242.7 | 242.7 | 179.5 | 87.5 | 28.2 | 9.1 | 9.0 | 9.7 | 7.3 | 5.5 | 5.4 | |
| Gross Profit | 362.8 | 362.8 | 262.1 | 154.1 | 65.3 | 21.2 | 16.6 | 13.9 | 5.7 | 2.1 | 0.8 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 160.8 | 143.8 | 157.4 | 143.5 | 121.6 | 108.8 | 114.3 | 96.9 | 81.2 | 66.4 | |
| Cost of Revenues | 67.4 | 59.2 | 60.8 | 55.3 | 49.6 | 47.9 | 45.1 | 37.0 | 33.3 | 25.8 | |
| Gross Profit | 93.4 | 84.6 | 96.6 | 88.2 | 72.0 | 60.8 | 69.2 | 59.9 | 47.9 | 40.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 36.1 | 26.8 | 22.3 | 18.8 | 19.9 | 13.7 | 15.0 | 15.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 119.6 | 69.9 | 38.3 | 24.2 | 23.6 | 12.3 | 7.6 | 8.1 | |
| Depreciation & Amortization | 27.2 | 27.2 | 19.8 | 8.2 | -1.0 | -0.9 | 1.7 | 0.8 | 0.8 | 0.6 | 0.4 | |
| Total Operating Expenses | 254.2 | 254.2 | 224.6 | 182.8 | 96.7 | 60.6 | 43.0 | 43.5 | 26.0 | 22.6 | 23.8 | |
| Operating Income | 108.6 | 108.6 | 37.5 | -28.7 | -31.4 | -39.4 | -26.4 | -29.6 | -20.2 | -20.4 | -23.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.8 | 38.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 34.6 | 30.7 | ||
| Depreciation & Amortization | 7.5 | 6.8 | 6.7 | 6.1 | 5.7 | 5.2 | 4.6 | 4.4 | 3.7 | 1.9 | ||
| Total Operating Expenses | 72.1 | 61.3 | 60.0 | 60.8 | 63.4 | 56.9 | 56.7 | 47.4 | 45.3 | 69.0 | ||
| Operating Income | 21.3 | 23.3 | 36.6 | 27.4 | 8.6 | 3.9 | 12.5 | 12.4 | 2.6 | -28.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.5 | 0.0 | 0.0 | 12.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 13.8 | 13.8 | 14.4 | 10.8 | 3.7 | 3.9 | 4.0 | 4.4 | 2.7 | 1.1 | 1.0 | |
| Other Expense | -1.1 | -1.1 | -1.7 | 2.1 | -4.7 | -4.8 | -2.3 | -3.9 | -0.8 | 0.7 | -0.1 | |
| IBT | 107.5 | 107.5 | 35.8 | -26.7 | -36.2 | -44.2 | -28.7 | -33.5 | -23.7 | -20.8 | -24.1 | |
| Income Tax Expense | -82.8 | -82.8 | 0.3 | -1.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | |
| Net Income | 190.3 | 190.3 | 35.5 | -25.0 | -36.2 | -44.2 | -28.7 | -33.5 | -23.8 | -20.8 | -24.1 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 2.5 | 0.0 | 2.9 | 3.3 | 3.4 | 3.6 | 4.8 | 5.2 | ||
| Interest Expense | 3.4 | 3.5 | 3.5 | 3.5 | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 | ||
| Other Expense | 0.4 | -0.3 | -0.4 | -0.8 | -1.7 | 0.3 | -0.4 | 0.0 | 1.3 | 1.4 | ||
| IBT | 21.6 | 23.0 | 36.2 | 26.7 | 7.0 | 4.2 | 12.2 | 12.4 | 3.9 | -26.9 | ||
| Income Tax Expense | -83.8 | -1.3 | 1.3 | 1.0 | 0.1 | 0.0 | 0.0 | 0.2 | -0.2 | -1.5 | ||
| Net Income | 105.4 | 24.3 | 34.9 | 25.7 | 6.9 | 4.2 | 12.2 | 12.2 | 4.0 | -25.4 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.77 | $-1.23 | $-1.60 | $-1.16 | $-2.36 | $-1.23 | $-1.44 | $-1.66 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.77 | $-1.23 | $-1.60 | $-1.16 | $-2.36 | $-1.23 | $-1.44 | $-1.66 | |
| Shares Outstanding | 34.2 | 34.0 | 33.2 | 32.5 | 29.6 | 27.6 | 24.7 | 14.2 | 19.2 | 14.5 | 14.5 | |
| Diluted Shares Outstanding | 40.9 | 40.5 | 35.2 | 32.5 | 29.6 | 27.6 | 24.7 | 14.2 | 19.2 | 14.5 | 14.5 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $-0.78 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $-0.78 | ||
| Shares Outstanding | 34.2 | 34.1 | 33.9 | 33.7 | 33.6 | 33.4 | 33.1 | 32.8 | 32.6 | 32.6 | ||
| Diluted Shares Outstanding | 40.9 | 40.7 | 40.6 | 39.9 | 35.2 | 35.7 | 35.3 | 34.7 | 34.2 | 32.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 362.8 | 336.7 | 394.8 | 201.2 | 25.6 | 24.6 | 20.1 | 20.2 | 11.9 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 66.9 | 101.1 | 60.6 | 0.0 | 12.7 | |
| Total Cash & ST Investments | 362.8 | 336.7 | 394.8 | 201.2 | 92.5 | 125.6 | 80.7 | 20.2 | 24.7 | |
| Accounts Receivable | 81.2 | 97.7 | 63.6 | 27.6 | 5.9 | 6.9 | 6.6 | 3.4 | 0.9 | |
| Inventory | 48.7 | 46.6 | 44.2 | 20.6 | 14.9 | 11.9 | 11.2 | 9.3 | 8.0 | |
| Other Current Assets | 16.7 | 16.3 | 8.0 | 2.9 | 5.5 | 2.3 | 1.5 | 1.8 | 0.5 | |
| Total Current Assets | 509.3 | 497.2 | 510.7 | 252.3 | 118.7 | 146.8 | 100.0 | 34.8 | 34.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 466.2 | 400.6 | 310.1 | 336.7 | 330.1 | 362.8 | 350.2 | 394.8 | 427.1 | 582.2 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 466.2 | 400.6 | 310.1 | 336.7 | 330.1 | 362.8 | 350.2 | 394.8 | 427.1 | 582.2 | |
| Accounts Receivable | 80.7 | 104.9 | 142.0 | 97.7 | 90.1 | 81.2 | 81.9 | 63.6 | 60.7 | 47.5 | |
| Inventory | 44.5 | 38.9 | 43.4 | 46.6 | 52.2 | 48.7 | 48.5 | 44.2 | 39.4 | 30.5 | |
| Other Current Assets | 21.6 | 13.8 | 10.4 | 16.3 | 20.1 | 16.7 | 7.6 | 8.0 | 9.6 | 2.4 | |
| Total Current Assets | 613.0 | 558.1 | 505.9 | 497.2 | 492.5 | 509.3 | 488.3 | 510.7 | 536.7 | 662.7 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 234.9 | 292.5 | 180.5 | 24.4 | 15.7 | 4.8 | 4.8 | 3.5 | 2.5 | |
| Goodwill | 11.5 | 11.5 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 2.3 | 2.2 | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.1 | 0.7 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 3.9 | 0.5 | |
| Total Long-Term Assets | 249.3 | 306.9 | 195.4 | 24.9 | 16.2 | 5.3 | 5.3 | 7.4 | 3.0 | |
| Total Assets | 758.6 | 804.1 | 706.0 | 277.1 | 134.9 | 152.0 | 105.3 | 42.2 | 37.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 318.8 | 318.1 | 317.3 | 292.5 | 278.7 | 234.9 | 220.6 | 180.5 | 137.9 | 26.9 | |
| Goodwill | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 12.0 | 12.0 | 11.7 | 0.0 | |
| Intangible Assets | 2.0 | 2.0 | 2.1 | 2.2 | 2.2 | 2.3 | 2.3 | 2.4 | 2.4 | 0.0 | |
| Long-Term Investments | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.8 | |
| Other Long-Term Assets | 0.7 | 0.2 | 0.7 | 0.7 | 0.7 | 0.1 | 0.1 | 0.1 | 0.6 | 0.1 | |
| Total Long-Term Assets | 333.0 | 332.4 | 331.6 | 306.9 | 293.1 | 249.3 | 235.5 | 195.4 | 152.5 | 27.7 | |
| Total Assets | 946.0 | 890.5 | 837.5 | 804.1 | 785.6 | 758.6 | 723.8 | 706.0 | 689.2 | 690.4 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.0 | 10.3 | 12.7 | 3.3 | 6.7 | 1.2 | 7.2 | 4.7 | 3.5 | |
| Short-Term Debt | 2.1 | 2.7 | 4.1 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | |
| Other Current Liabilities | 37.7 | 45.2 | 36.2 | 18.6 | 16.3 | 10.4 | 8.7 | 7.5 | 5.3 | |
| Current Liabilities | 54.3 | 59.9 | 54.9 | 23.7 | 23.2 | 11.9 | 16.1 | 12.6 | 10.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 12.2 | 9.5 | 10.6 | 10.3 | 13.1 | 13.0 | 9.2 | 12.7 | 12.8 | 7.0 | |
| Short-Term Debt | 8.2 | 3.0 | 2.8 | 2.7 | 5.1 | 4.3 | 2.1 | 4.1 | 4.0 | 3.8 | |
| Other Current Liabilities | 56.0 | 42.5 | 40.1 | 45.2 | 39.6 | 35.6 | 36.9 | 36.2 | 29.7 | 21.0 | |
| Current Liabilities | 79.7 | 56.6 | 55.6 | 59.9 | 60.0 | 54.3 | 50.2 | 54.9 | 49.1 | 32.0 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 507.8 | 515.6 | 513.9 | 66.1 | 8.6 | 34.7 | 34.1 | 33.7 | 6.8 | |
| Capital Leases | 6.6 | 9.0 | 9.7 | 8.9 | 8.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 568.7 | 575.5 | 568.8 | 89.8 | 67.0 | 48.1 | 50.7 | 47.0 | 205.7 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 456.5 | 515.8 | 515.6 | 515.6 | 515.6 | 514.4 | 514.1 | 513.9 | 513.7 | 513.1 | |
| Capital Leases | 7.7 | 0.0 | 8.3 | 9.0 | 9.6 | 6.6 | 7.2 | 7.7 | 10.2 | 10.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 590.8 | 572.4 | 571.2 | 575.5 | 575.7 | 568.7 | 564.4 | 568.8 | 562.8 | 545.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 669.4 | 697.2 | 641.1 | 666.3 | 510.5 | 502.2 | 424.1 | 331.2 | 0.0 | |
| Retained Earnings | -479.3 | -468.2 | -503.7 | -478.7 | -442.4 | -398.2 | -369.5 | -335.9 | -312.2 | |
| Comprehensive Income | -0.2 | -0.4 | -0.2 | -0.2 | -0.2 | -0.1 | 0.0 | -0.1 | -0.1 | |
| Total Common Equity | 189.9 | 228.6 | 137.2 | 187.4 | 67.9 | 103.9 | 54.6 | -4.8 | -168.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 738.4 | 725.7 | 709.2 | 697.2 | 685.3 | 669.4 | 651.2 | 641.1 | 634.5 | 627.7 | |
| Retained Earnings | -383.3 | -407.7 | -442.6 | -468.2 | -475.1 | -479.3 | -491.5 | -503.7 | -507.7 | -482.3 | |
| Comprehensive Income | 0.1 | 0.1 | -0.3 | -0.4 | -0.2 | -0.2 | -0.2 | -0.2 | -0.3 | -0.2 | |
| Total Common Equity | 355.2 | 318.1 | 266.3 | 228.6 | 209.9 | 189.9 | 159.5 | 137.2 | 126.5 | 145.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 516.5 | 518.3 | 515.9 | 67.6 | 8.6 | 34.7 | 34.1 | 33.7 | 8.7 | |
| Book Value | 189.9 | 228.6 | 137.2 | 187.4 | 67.9 | 103.9 | 54.6 | -4.8 | -168.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 355.2 | 318.1 | 266.3 | 228.6 | 209.9 | 189.9 | 159.5 | 137.2 | 126.5 | 145.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3.0 | 190.3 | 35.5 | -25.0 | -36.2 | -44.2 | -28.7 | -33.5 | -23.8 | -20.8 | -24.1 | |
| Depreciation & Amortization | 14.6 | 27.2 | 19.8 | 8.2 | 3.5 | 1.8 | 1.6 | 1.2 | 0.8 | 0.6 | 0.4 | |
| Stock-Based Compensation | 25.4 | 36.9 | 33.2 | 19.8 | 10.3 | 6.9 | 2.4 | 0.9 | 0.1 | 0.1 | 0.0 | |
| Change Working Capital | -49.0 | 17.3 | -45.0 | -44.3 | -26.8 | 3.0 | -5.6 | -1.6 | -4.3 | -2.8 | -0.9 | |
| Change In Accounts Receivable | -31.6 | 14.0 | -34.3 | -33.8 | -21.7 | 0.8 | -0.2 | -3.2 | -2.5 | 0.5 | -0.8 | |
| Change In Accounts Payable | 5.1 | 0.0 | -1.4 | 7.0 | -3.3 | 5.1 | -5.8 | 3.4 | 0.2 | -0.7 | 1.1 | |
| Change In Inventories | -25.0 | -7.7 | -8.4 | -28.1 | -8.0 | -4.9 | -1.7 | -4.1 | -2.7 | -2.5 | -1.6 | |
| Other Non-cash Items | 87.4 | 4.8 | 5.4 | 30.0 | 3.4 | 1.4 | 0.5 | 0.5 | 0.2 | 0.1 | 0.1 | |
| Cash from Operations | 23.7 | 0.0 | 0.0 | -13.0 | -45.8 | -28.9 | -30.3 | -32.3 | -26.0 | -23.1 | -24.1 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 105.4 | 24.3 | 34.9 | 25.7 | 6.9 | 4.2 | 12.2 | 12.2 | 4.0 | -25.4 | |
| Depreciation & Amortization | 7.5 | 6.8 | 6.7 | 6.1 | 5.7 | 5.2 | 4.6 | 4.4 | 3.7 | 1.9 | |
| Stock-Based Compensation | 9.4 | 9.1 | 9.4 | 9.0 | 10.8 | 0.0 | 0.0 | 0.0 | 5.7 | 5.2 | |
| Change Working Capital | -4.9 | 27.9 | 40.2 | -44.4 | -5.8 | -11.2 | 0.2 | -28.1 | -5.6 | -15.5 | |
| Change In Accounts Receivable | -3.6 | 24.1 | 37.5 | -44.1 | -7.8 | -8.8 | 0.8 | -18.4 | -2.8 | -11.1 | |
| Change In Accounts Payable | -2.1 | 2.5 | -1.2 | 0.8 | -3.1 | 0.0 | 3.8 | -2.0 | 0.4 | 2.9 | |
| Change In Inventories | -6.5 | -6.9 | 3.7 | 2.0 | 4.1 | -4.6 | -2.3 | -5.6 | -7.1 | -10.1 | |
| Other Non-cash Items | 0.8 | 1.3 | 0.4 | 0.8 | 2.2 | 8.7 | 8.7 | 8.1 | 0.5 | 28.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.3 | -6.9 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -244.7 | -59.3 | 0.0 | -151.8 | -11.9 | -3.5 | -0.5 | -0.2 | -0.4 | -0.3 | -1.5 | |
| Acquisitions | 0.0 | 0.0 | 0.4 | -14.9 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | -10.5 | -72.0 | -121.8 | -82.4 | 0.0 | -19.2 | -46.5 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 76.9 | 104.8 | 80.7 | 22.0 | 12.7 | 44.3 | 8.3 | |
| Other Investing Activities | -69.3 | 0.0 | 0.0 | -27.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -259.6 | 0.0 | 0.0 | -194.0 | 54.5 | 29.3 | -41.6 | -60.5 | 12.3 | 24.9 | -39.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -15.5 | -7.6 | -9.1 | -27.0 | -13.6 | -48.2 | -23.8 | -44.2 | -41.8 | -134.9 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 14.9 | -14.9 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -42.1 | -27.2 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -41.8 | -149.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -407.9 | 0.0 | 0.0 | 445.4 | -36.1 | 0.0 | -2.2 | 0.0 | -9.1 | 0.0 | 0.0 | |
| Debt Issued | 409.4 | 518.3 | 2.3 | 893.8 | 95.0 | -26.1 | 2.8 | 0.5 | 34.1 | 8.7 | 0.0 | |
| Issuance of Common Stock | 16.3 | 0.0 | 0.0 | 0.0 | 139.9 | 0.0 | 75.7 | 97.4 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 1.2 | -0.1 | 0.0 | 1.0 | 0.5 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 1.7 | 0.0 | 0.0 | -52.1 | 63.6 | 1.0 | 2.1 | -4.6 | 31.1 | 0.0 | 63.5 | |
| Cash from Financing | 16.3 | 0.0 | 0.0 | 400.4 | 167.9 | 1.4 | 75.5 | 92.7 | 22.1 | 0.0 | 63.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 464.7 | -54.1 | 0.4 | 0.1 | 0.1 | 1.7 | 0.3 | 0.3 | 0.3 | 0.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.5 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.5 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.5 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -219.7 | 151.7 | -58.2 | 193.6 | 175.6 | 1.0 | 4.5 | -0.1 | 8.3 | 2.1 | -0.2 | |
| Closing Cash Balance | 362.8 | 488.9 | 337.2 | 395.3 | 201.7 | 26.1 | 25.1 | 20.6 | 20.7 | 12.4 | 10.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 22.2 | 65.6 | 90.4 | -26.5 | 6.6 | -32.7 | 12.5 | -44.6 | -32.3 | -155.4 | |
| Closing Cash Balance | 488.9 | 466.2 | 401.1 | 310.6 | 337.2 | 330.1 | 362.8 | 350.2 | 394.8 | 427.6 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -221.0 | 133.6 | -80.9 | -192.1 | -57.7 | -32.4 | -30.7 | -32.5 | -26.4 | -23.4 | -25.6 | |
| Real Free Cash Flow | -246.4 | 96.7 | -114.2 | -211.9 | -68.0 | -39.3 | -33.1 | -33.3 | -26.5 | -23.4 | -25.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 19.0 | 61.9 | 82.5 | -29.9 | 6.1 | -41.3 | 2.0 | -47.6 | -33.5 | -141.8 | |
| Real Free Cash Flow | 9.6 | 52.8 | 73.2 | -38.9 | -4.7 | -41.3 | 2.0 | -47.6 | -39.2 | -147.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 24.5 | 73.1 | 179.3 |
| P/S | 7.7 | 17.8 | 390.6 |
| P/B | 13.1 | 10.8 | 113.4 |
| P/FCF | 48.2 | -23.6 | 149.9 |
| Market cap | $4.2 | $19.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 49.1 % | 38.2 % | 0 % |
| Debt to Income | 244.2 % | 241.2 % | 0 % |
| Debt to Free cash flow | 480.5 % | -75.3 % | 0 % |
| Interest expense percentage | 12.7 % | -69.4 % | 11.2 % |
| Current ratio | 7.7 | 7.6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 53.6 % | -0.1 % | 0 % |
| ROA | 20.1 % | -16.4 % | 0 % |
| CapEx to Revenue | 10.1 % | 16 % | 6 % |
| RaD to Revenue | 0 % | 58.1 % | 0 % |
| ROEM | 831,722.5 | 170885.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 60.3 % | 60.6 % | 61.9 % |
| Operating margin | 16.9 % | -77.5 % | 17.9 % |
| Net margin | 16.2 % | -87.4 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 40.7 mil | 27.7 mil |
| Employee count | 0.7 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
